2nd Quarter - Report
ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions S. 2700 (FDA and NIH Workforce Authorities Modernization Act), Section 16, regarding FDA guidances
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES RAVITZ | — |
| DAN RENBERG | — |
Medicare/Medicaid MMM
Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES RAVITZ | — |
| DAN RENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.